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Abstract
The objective of the present study was to implant a method using a
sensitive and specific system, and validate the whole analytical method
to obtain an efficient tool for analyses of tramadol in plasma dogs,
and to evaluate the pharmacokinetics of tramadol following
intravenous (i.v.) and intramuscular (i.m.) administration of  this drug
in females dogs submitted to castration. The pharmacokinetics of
tramadol were examined following i.v. or i.m. tramadol administration
to five female dogs in each group submitted to ovariohysterectomy
(dosage=2 mg/kg). In relation to intravenous administration, the
half-time for the distribution process (t1/2d = 0.18 ± 0.12 h); the total
body clearance was 0.60 ± 0.50 L/h/kg, half-life of elimination (t1/2b)
was 1.24 ± 0.69 h. Statistically differences between parameters obtained
after i.v. and i.m. was significant only to AUC0–∞: 3362.07 ± 1008 and
1604.55 ± 960.02 (ng.h/mL), respectively. The F was 48.00 ±
43.30 %. The assay for tramadol described has been demonstrated to
meet all requirements for clinical PK studies. In particular, the method








Tramadol hydrochloride, (1RS, 2RS)-
[(dimethylamin) methyl]-1-(3-methoxyphenyl)
cyclohexanol HCl, is a centrally acting opioid
analgesic in wide spread human clinical use.1
It is a synthetic analogue of codeine, but has
a relatively low affinity for opiate receptors.
Tramadol has been used for postoperative
analgesia following orthopedic surgery and
major gynecologic surgeries in addition to
nonsurgical conditions in humans.2,3,4,5
Tramadol is well absorbed and
extensively metabolized after oral
administration in human beings, and its
metabolites are excreted primarily in the
urine.6 Unchanged tramadol and a total of
twenty four metabolites, consisting of sixteen
phase I metabolites and eight conjugates
(seven glucuronides, one sulfate), were
isolated in the urine of  dogs and rats.7
Minimum effective plasma concentration in
human beings for tramadol and O-
desmethyltramadol, an active metabolite,
have been reported to be 298 ± 171-590 ±
410 and 39.6 ± 29.5 – 84 ± 34 ng/mL,
respectively in postoperative human
patients. 4,8
At “Veterinary Hospital of  University
of São Paulo”, tramadol has been used as
analgesic after ovariohysterectomy
(castration) of  female dogs. Therefore, there
is a lack of  pharmacokinetics data of
tramadol in this animal specie by
intramuscular (i.m.) route of administration.
Thus, the objective of the present work was
to: (i) implant a method using a sensitive and
specific system, and validate the whole
analytical method to obtain an efficient tool
for analyses of tramadol in plasma dogs, and
(ii) evaluate the pharmacokinetics (PKs) of
tramadol following intravenous (i.v.) and
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intramuscular (i.m.) administration of this
drug in females dogs submitted to castration.
Material and Method
Ten adult mixed breed female dogs
were enrolled in this study between March
and December 2005. The mean age was 2.75
years old (range: 1 – 6 years) and the mean
body weight was 28.89 kg (range: 15 – 55.7
kg). All animals were considered healthy,
based on physical examination, complete
blood count, plasma biochemistry profile
and urinalysis. All procedures related to this
study were performed in accordance with
The Institutional Animal Care and Use
Committee at Faculdade de Medicina
Veterinária e Zootecnia, Universidade de São
Paulo.
The dogs were anaesthetized prior to
and during ovariohysterectomy surgery with
acepromazine, propofol and isoflurane.
After the last stitch, each the dogs were
randomly allocated in one of the two groups
and administered a single dose of tramadol
HCl commercial injection (Cristália, Brazil)
(2 mg of tramadol per kg of body weight),
i.v. via jugular vein or i.m. injected deep into
semimembraneous muscle.
A jugular catheter was placed in the
right jugular vein prior to surgery. Blood
samples, 10 mL per sample, were collected
in tubes containing sodium heparin as
anticoagulant and centrifuged at 2000 g for
10 min. The plasma was decanted, labeled,
frozen at - 80 ºC until the assays were
performed within 60 days of  collection. This
period is inferior to that established by Gan
et al. 9 which is stable for more than 1 year
when stored at - 20 ºC. Samples were
collected immediately before tramadol
administration (0) and at 10, 20, 30, 45
minutes and 1.00, 1.50, 2.00, 3.00, 4.00, 5.00,
6.00 hours after tramadol administration.
Stock solutions of tramadol were
prepared monthly by dissolving 11.38 mg
of tramadol hydrochloride (Sigma®,
Germany) in 100 mL of  methanol (100 μg/
mL) and kept stored at 4°C. Standard curve
for plasma analysis were prepared by
fortifying pooled fresh canine plasma with
stock solution of tramadol hydrochloride to
produce a concentration range from 10 to
2000 ng/mL. The fortified calibration
samples were processed and prepared
exactly as described bellow for the incurred
plasma samples. Tramadol concentrations for
the calibration curve were: 10, 50, 125, 250,
500, 1000 and 2000 ng/mL. These working
solutions were made by further dilution of
the stock solutions in methanol and they were
prepared fresh daily. Deionized water was
produced by a Milli-Q Millipore Water
System (Millipore, MA, USA).
Intra-assay precision and accuracy
were determined by measuring five replicates
of each of three standard concentration
(100, 750 and 1500 ng/mL) prepared in fresh
dog plasma and then stored. Interassay
precision and accuracy were estimated by
assaying three plasma concentrations on four
different days. Recovery was estimated by
comparing the slope of  the standard curves
for extract plasma with that for the
corresponding unextracted standards.
Plasma concentrations of tramadol
were analyzed by high-performance liquid
chromatography (HPLC model LC-10AD
with UV-VIS spectrophotometric detector
model SPD-10AV, Shimadzu, Analytical
Instruments Division, Kyoto, Japan) at
Laboratório de Farmacologia from
Departamento de Patologia da Faculdade
de Medicina Veterinária e Zootecnia da
Universidade de São Paulo. The HPLC
method was based on previously published
method 9,10,11  with modifications made to
improve the efficiency of  the method. For
the analyses, frozen dog plasma samples were
left on the bench to thaw naturally and were
vortexed prior to their use. Plasma extraction
was accomplished with liquid-liquid
extraction. Briefly, to the plasma was added
5 drops of 0.1 M sodium hydroxide prior
to the extraction. The solution was
thoroughly vortexed. Then, 4 mL of ethyl
acetate: hexane (1:4) (HPLC grade, Merck,
Darmstadt, Germany) was added into the
plasma and vortexed for 1.5 min.
Afterward, it was subjected to centrifugation
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at 3500 g for 15 min. The organic layer was
transferred into Cahan’s tubes.
The tubes were then passed through a
stream of nitrogen for drying (15 min)
and 50 ml of the mobile phase was added
for reconstitution before injection
to the HPLC system. The analytical column
was a RP-18 with particle size of 5 μm
maintained at 55oC (Shimadzu, Maryland,
USA). The mobile phase was constituted of
70% 0.01 M phosphate buffer adjusted to a
pH of 5.9 with phosphoric acid (both of
analytical reagent-grade from Merck,
Darmstadt, Germany) with 0.1%
triethylamine and 30% acetonitrile (HPLC
grade, Merck Darmstadt, Germany). The
UV detector was set to an excitation
wavelength of 218 nm. The volume of each
injection was 10 μL. Retention time for
tramadol was 9.13 min and rate flow
1.2 mL/min.
Data analysis
Individual tramadol concentration vs.
time curves was analyzed by non linear least
square regression analysis using GraphPad
Prism (1999). Choice of appropriate
pharmacokinetic model was prepared on
the basis of the lowest weighted sum of
squares and lowest Akaikes’s information
criterion value for the individual data 12.
Following i.v. administration the final
pharmacokinetic model fit the data was a
two-compartment open model with first-
order elimination from the central
compartment in all the animals (Eqn 1):
C(t) = A e (-αt) + B e (βt) (1)
where C(t) (ng/mL) represents tramadol
plasma concentration at time t; A and B
(ng/mL) are the concentration extrapolated
to time 0 of the first and second phase of
tramadol plasma and α and β (1/h) are the
distribution and elimination slopes,
respectively.
Plasma tramadol distribution and
elimination half-lives, t1/2(d) and t1/2β,
respectively, were calculated by Eqns
2 and 3:
t1/2(d) = 0.693/α (2)
t1/2β = 0.693/β (3)
Area under the plasma curve from 0
to infinity (AUC0–∞) and area under the
first moment curve from 0 to infinity
(AUMC0–∞) were calculated by the linear
trapezoidal method with extrapolation to
infinity. The extrapolated area was estimated
by Eqn 4 and 5:
AUClast–∞ = Clast/β(4)
AUMClast–∞ = (tlast x Clast/β) + Clast/kel2 (5)
In which Clast is the last measured
concentration, t is the time of Clast, and kel
was the elimination constant.
Total body clearance (ClT) was
determined by Eqn (6):
ClT = dose/ AUC0–∞ (6)
Mean residence time (MRT) was
determined by Eqn (7):
MRT = AUC0–∞/ AUMC0–∞ (7)
The apparent volume of distribution
area was calculated by Eqn 8:
Vd(area) = dose/ (AUC0–∞ x β) (8)
The volume of central compartment
was calculated by Eqn 9:
V1 = dose/ Cp0 (9)
Where Cp0 = A+B
The micro constants were calculated
by Eqn 10-12:
k21 = (αB + Aβ)/A + B (10)
kel = αβ/k21 (11)
k12 = α + β – k21 - kel (12)
Compartmental analysis parameters
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were calculated from equations published
elsewhere.13 They are presented in table 1.
Tramadol plasma disposition curves
after i.m. administration, were analyzed
following the same procedure as used for
i.v. analysis. Peak concentrations (Cmax) of
tramadol in blood and the time of peak
concentration (Tmax) were obtained directly
from the experimental data without
interpolation. Systemic bioavailability (F) of
tramadol was calculated from
noncompartmental parameters using
Eqn (13):
F = (AUC0–∞ i.m. / AUC0–∞ i.v.) x 100 (13)
Variance analysis (ANOVA) followed
by Unpaired t test with Welch correction was
used to analyze data from pharmacokinetic
parameters. The results were presented as the
mean with their standard deviation. All
analyses were realized using the software
GraphPad Instat 14 and the figure by using
GraphPad Prism 15. In all experiments,
P<0.05 was the criterion for statistical
significance.
Results
 The linear concentration range for
tramadol analysis was 10 to > 2000 ng/mL
(n=7) (r2 > 0.999). The limit of detection
and quantification were found to be,
respectively, 10 ng/mL and 50 ng/mL. The
recoveries at 100, 750 and 1500 ng/mL were
87.5%, 87.7% and 86.5%, respectively. Intra-
Table 1 - Mean ± SD values for tramadol pharmacokinetic variables following intravenous (i.v.) and intramuscular
(2 mg/kg) tramadol HCl administration to five adult female dogs, in each group, after ovariohysterectomy.
Plasma concentration of tramadol was measured by high-performance liquid chromatography (HPLC)
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and inter-day precision values for quality
control samples were 2.2-3.2 and 2.8-3.3%
coefficient of  variation (CV), respectively. In
terms of  stability, no significant degradation
of  tramadol was observed under any of
the storage conditions evaluated. There were
no interfering peaks from control plasma
matrix, hemolyzed or not, and the presence
of acepromazine, propofol and isoflurane
in the plasma. Mean retention time for
tramadol was 9.13 min (Figure 1).
No adverse effects were noted after
i.v. or i.m. administration of  tramadol HCl
at 2.0 mg/kg. All twelve dogs appeared
mildly sedated after administration. Blood
levels of  tramadol administrated by i.v. and
i.m are presented in figure 2 and the PK data
are presented in table 1.
Blood samples taken from all
evaluated animals before tramadol
administration were found to contain no
measurable levels of  this drug. On the other
hand, they presented high tramadol levels
after dosage. By i.m. the highest tramadol
concentration occurred at 0.75 ± 0.25 h
(625.50 ± 24.99 ng/mL). In both routes
these levels were measurable until 6 hours
after tramadol administration. Tramadol
levels were significantly higher by i.v. than i.m
at all time evaluated.
A two-compartment model best fit
the plasma concentrations after intravenous
tramadol in all dogs. A one-compartment
model with first-order input was fit to the
plasma tramadol concentrations following
i.m administration.
In relation to intravenous administration,
tramadol serum concentration rapidly
decreased during the first hour
postadministration, as reflected by the half-
time for the distribution process (t1/2d = 0.18
± 0.12 h). Distribution was wide, with a Vd1
of  0.33 ± 0.21 L/kg and a Varea of  1.06 ±
0.53 L/kg. The k12/k21 ratio was 1.15 ± 0.58,
indicating that the drug is returning rapidly
from distribution sites for elimination from
the body. Total body clearance was relatively
rapidly (0.60 ± 0.50 L/h/kg). Half-life of
Figure 1 - Representative chromatograms obtained from (A) tramadol free dog plasma and (B) dog plasma from the
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elimination (t1/2b) was 1.24 ± 0.69 h and a
MRT of 1.08 ± 0.63.
On the other hand, calculated
parameters in relation to i.m. administration
showed the same median value to the total
body clearance (0.59 ± 0.38 L/h/kg); the
i.m. absorption was rapid as reflected
by the Tmax (0.75 ± 0.25 h) and t1/2abs (1.08 ±
0.62 h). Moreover, statistically differences
between parameters obtained after i.v. and
Figure 2 - Plasma concentration (ng/mL) profiles as measured by HPLC in adult female dogs after a single i.v. or i.m.
administration of tramadol. Dosage = 2 mg/kg
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i.m. was significant only in the AUC0’! “:
3362.07 ± 1008.60 and 1604.55 ± 960.02
(ng.h/mL), respectively. The F was 48.00 ±
43.30 %.
Discussion/Conclusion
Our study verified if the HPLC
method previously published 9 to measure
tramadol in human plasma was also
appropriate to the dog plasma because this
technique employees equipment and reagents
available in our laboratory. The parameters
analyzed showed that it is an effective
technique with the advantages of being rapid,
easy to perform and inexpensive.
This method has been successfully
applied to the analyses of samples for a PK
study in the present experiment which
consisted of twelve dogs submitted to
anesthesia with propofol, acepromazine and
isoflurane and then submitted to castration.
The dose of tramadol administered in the
present investigation (2.0 mg/kg), in the end
of the surgical procedure, was chosen taking
into account previous studies 16 in which this
dose was verified not to produce the typical
adverse effects reported for tramadol and
also because this dose generates detectable
blood concentrations of the compound in
treated animals.
Early studies in 1999 16 demonstrated
the analgesic effects of single-dose
intramuscular tramadol 50-100 mg in
human. Several studies have confirmed that
repeated intramuscular administration of
tramadol can provide effective and well
tolerated postoperative analgesia comparable
to that obtained with morphine, pentazoine
and ketorolac.17 In this way, we elected the
i.m and i.v. routes as they are the main routes
of drug administration after surgical
procedures and also because there isn’t any
study comparing these two routes in dogs
that received tramadol.
The tramadol plasma concentration
vs time data after intravenous administration
were best fitted to a two-compartment open
model. This conclusion is in agreement with
that found in previous studies of tramadol
carried out in dogs.16 An open one-
compartment model with first-order
absorption best fitted the data obtained after
intramuscular administration of tramadol to
female dogs.
Mean residence time (MRT) reflects
the difference in persistence of the drug in
the body after intravenous and intramuscular
administration. The prolonged MRT after
intramuscular administration compared to
the intravenous administration, the clearances
being similar, was due to the influence of
the absorption phase. Similar results have
been reported in dogs that received tramadol
per os and intravenous.16
It was estimated that about 2% of
the absorbed tramadol is excreted unchanged
in the urine of dogs and more than 24
metabolites are excreted, which are almost
completely eliminated through the kidneys.7
In healthy humans, the average elimination
half-life of tramadol was estimated at 6h,
whereas in patients with renal insufficiency
the dose must be adjusted according to the
clearance renal values.17 Assuming that the
slower the elimination of this substance, the
longer the time it will remain in the body, it
could be inferred that both i.v. and i.m.
dosing should expose the dogs lesser to
tramadol than in human beings, as in the
present study the elimination half-life of
tramadol was 1.24 ± 0.69 and 1.82 ± 1.01,
by i.v. and i.m., respectively.
The absorption process was rapid
with a Tmax range: 0.50 - 1.00 h and
corroborated by the absorption rate constant
(ka) and t1/2abs. The Cmax range: 650.49 –
600.51 ng/mL and the corresponding results
after i.m. in humans was C(max) = 166 (1.24)
ng/ml 6, which was inferior what could be
in part be explained by the dose
administered to human which was
< 1 mg/kg. The F of  the drug after i.m.
administration at 2 mg/kg b.w. was
48.00 ± 43.30, in the present study. The low
F values indicate that the drug was not
completely absorbed from i.m. site injection
in dogs. In contrast to its pharmacokinetics
in humans, Ground et al.6 and Lintz, Beier
and Gerloff18  founded 92.9 - 105.4%. Thus,
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the results reflect the different kinetics
between human and dogs
The volume of distribution area for
tramadol was 1.06 ± 0.53 and volume of
distribution of central compartment was
0.33 ± 0.21 L/kg, which is consistent with a
high tissue affinity. On the other hand,
extrapolation of this data should be viewed
with caution when considering multidose
studies as it has been well determined that
many differences exist in biochemical,
morphological and functional changes
between single and prolonged exposure
to drugs.13
In summary, taken as a whole, the
present data strongly support that exposition
to tramadol was able to raise the levels in
the plasma of dogs submitted to castration.
The assay for tramadol described has been
demonstrated to meet all requirements for
clinical PK studies. In particular, the method
has satisfactory specificity, linearity, accuracy
and precision range over the concentration
examined. The results from i.v. and i.m.
administration of tramadol reported here
provided the PK information for the design
of future studies of analgesic efficacy
in dogs.
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Farmacocinética do tramadol administrado pela via intravenosa e
intramuscular em cadelas submetidas a ovário - salpingo - histerectomia
Resumo
O objetivo do presente estudo foi de implantar um método sensível
e específico, e validar toda a metodologia para obter uma ferramenta
eficiente para a análise do tramadol em plasma de cadelas, e avaliar a
farmacocinética do tramadol após a administração do mesmo pelas
vias i.v. e i.m. em cadelas submetidas à castração. A farmacocinética do
tramadol foi examinada após a administração do tramadol por ambas
as vias, em cinco cadelas em cada grupo submetidas à ovário
histerectomia (dose = 2 mg/kg). Em relação à administração
intravenosa, a meia-vida de eliminação (t1/2b) foi de 1,24 ± 0,69 h.
Encontrou-se diferenças significantes somente nos parâmetros
AUC0–∞: 3362,07 ± 1008 and 1604,55 ± 960.02 (ng.h/mL), pelas vias
i.v. e i.m. respectivamente. O F foi de 48,00 ± 43,30 %. O estudo
descrito neste artigo demonstrou atingir todas as exigências para os
estudos clínicos em farmacocinética. Especificamente, o método
apresentou especificidade, linearidade, exatidão e precisão satisfatórias
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artigo. 4 - Não devem ser subdivididos
em seções separadas (Introdução,
Materiais e Métodos etc.), mas devem
apresentar, obrigatoriamente, dois
resumos, com palavras-chave, conforme
descrito na apresentação de Artigo
completo, além de referências.
Artigos de revisão
Só poderão ser publicados por
especialistas de renome a convite da
Comissão Editorial. Não devem ser
subdivididos em seções separadas
(Introdução, Materiais e Métodos etc.),
mas devem apresentar, obrigatoriamente,
dois resumos, com palavras-chave,
conforme descrito na apresentação de
Artigo completo, além de referências.
Apresentação dos trabalhos
1 - Digitação: original em CD,
devidamente identificado com o título
do artigo e nome do(s) autor(es) e três
cópias impressas, inclusive suas tabelas
e referências; deve ser digitado,
obrigatoriamente, em formato A4 (21,0
x 29,7cm), espaço duplo, em uma só
face de papel, margens de 2,5cm, fonte
Times New Roman tamanho 10 e
numeração consecutiva das páginas.
Ilustrações e legendas devem ser
relacionadas em folhas separadas. O texto
dos artigos deve ser apresentado
utilizando-se o editor de texto Microsoft
Word. 2 - Página de rosto: elemento
obrigatório, onde deve conter o título
do artigo, nome(s) do(s) autor(es) e
instituição de origem. Observar que
unicamente nesta página conste a
identificação dos autores, para o devido
sigilo e imparcialidade. No rodapé da
página deve-se mencionar o endereço
completo (inclusive e-mail) do autor para
correspondência. Se o artigo for
subvencionado, mencionar a instituição
que o patrocinou, assim como os
agradecimentos; 3 - Tabelas: devem ser
numeradas em algarismos arábicos e
encabeçadas pelo título, seguido de local
e data. Na montagem das tabelas seguir:
IBGE. Normas de apresentação tabular.
3. ed. Rio de Janeiro: IBGE, 1993. 61 p.
O limite de tabelas por trabalho é de
cinco. Em casos excepcionais,
conhecida a opinião da Comissão
Editorial, este número poderá ser
ultrapassado. No texto devem ser
indicadas pela palavra Tabela (por
extenso). 4 - Ilustrações (fotografias,
gráficos, quadros, desenhos ou
esquemas): devem ser numeradas
consecutivamente com algarismos
arábicos e citadas como figuras no texto.
As fotografias devem ser identificadas
somente com o título do artigo, além de
conter no verso a indicação de seu correto
posicionamento. Fotos fornecidas em
papel fotográfico devem ter ótima
resolução, em CD com a extensão .TIF e
resolução mínima de 300 dpi’s. As
legendas de ilustrações coloridas devem
estar referenciadas somente por setas,
símbolos e pontos quando publicadas
em preto e branco. Gráficos, desenhos
ou esquemas devem ser fornecidos no
CD, impressos em folha à parte
identificada somente com o título do
artigo, além das respectivas legendas.
Todas as ilustrações devem ser fornecidas
em três vias. Os gráficos devem trazer
sempre os valores numéricos que lhes
deram origem. Desenhos e esquemas
devem apresentar boa qualidade técnica
e artística. Aceitar-se-á um número
máximo de nove ilustrações por artigo,
sugerindo-se a seguinte distribuição: três
fotografias, três gráficos e três desenhos/
esquemas. Acima deste limite, as
despesas com reprodução correrão por
conta do autor. Ilustrações coloridas,
independentemente do número, serão
cobradas. No texto devem ser indicadas
pela palavra Figura (por extenso). Indicar
junto ao título da ilustração o local e
data.  5 - Referências: devem ser
numeradas, ao final do artigo, de forma
consecutiva de acordo com a ordem em
que forem sendo citadas no texto. Os
títulos de periódicos devem ser
mencionados de maneira uniforme, de
preferência todos por extenso. As
referências seguem a normalização da
Associação Brasileira de Normas Técnicas
(ABNT) NBR 6023, que deve ser
consultada para outros tipos de
documentos aqui não exemplificados.
Exemplos de Apresentação dos Autores
nas Referências:
BONAGURA, J. D. (um autor)
SANTOS, J. A.; MELLO, M. R. (dois
autores)
BENNETT, B. T.; ABEE, C. R.;
HENRICKSON, R. (três autores)
VILELA, D.; MARTINS, C. E.;
BRESSAN, M.; CARVALHO, L. A. [...]
(quatro autores ou mais) ou VILELA,
D. et al. (sem itálico).
Exemplo de periódico
1 KOTZEKIDOV, P.; BLOUKAS, J. G.
Effect of protective cultures and
packaging film permeatibility on
shelflife of sliced vacuum-pocked
cooked ham. Meat Science, v. 42, n. 3,
p. 333-345, 1996.
Exemplo de livro
2 HALLIWELL, R. E. W.; GORMAN, N.
T. Veterinary clinical immunology.
London: W. B. Saunders, 1989. 548 p.
Exemplo de autor diferente para o
livro e capítulo
3 FENNER, W. R. Avaliação
neurológica dos pacientes. In:
ETTINGER, S. J. Tratado de medicina
interna veterinária. 3. ed. São Paulo:
Manole, 1992. p. 577-606.
Exemplo de mesmo autor para o livro
e capítulo
4 THORTON, H. Deleterius changes in
meat. In: THORTON, H. Aspects of
meat inspection. London: Thindall &
Cassel, 1973. p. 63-72.
Exemplo de tese
5 BIRGEL, E. H. Estudo do quadro
eritrocitário de caprinos (Capra
hircus, L.) normais criados no Estado
de São Paulo: influências de fatores
raciais, sexuais, etários e alimentares.
1973. 92 f. Tese (Livre Docência) -
Faculdade de Medicina Veterinária e
Zootecnia, Universidade de São Paulo,
São Paulo, 1973.
Exemplo de evento
6 OLIVEIRA, C. A. Hormonoterapia em
cadelas e gatas. In: CONGRESSO
BRASILEIRO DE REPRODUÇÃO
ANIMAL, 9., 1991, Belo Horizonte.
Anais... Belo Horizonte: Colégio
Brasileiro de Reprodução Animal,
1991. p. 100-111.
Exemplo de livro eletrônico
7 POORE, M. H. Alternative feeds for
beef cattle. North Carolina: North
Carolina Corporative Extension Service,
1994. Disponível em: <http://
www.ces.ncsu.edu/drought/dro-
28.html>. Acesso em: 23 abr. 2007.
Exemplos de artigos de periódicos
eletrônicos
8 MENDONÇA JR., C. X.; MARTINS,
A. P.; MORI, A. V.; SILVA, A. B.;
MORI, C. S. Efeito da adição de óleo
de peixe à dieta sobre o desempenho e
níveis de lípides plasmáticos e de
colesterol no ovo de galinhas
poedeiras. Brazilian Journal of
Veterinary Research and Animal
Science, v. 37, n. 1, 2000. Disponível
em: <http://www.scielo.br/
cgi_bin/wxis.exe/iach/scielo>. Acesso
em: 31 jan. 2001
6 - Citações: utilizar o Sistema Numérico.
As citações devem ser feitas por
numeração única e consecutiva em
sobrescrito, utilizando-se algarismos
arábicos, remetendo à lista de referências
na mesma ordem em que aparecem no
texto. Quando indispensável para a
compreensão do texto, combinar o(s)
sobrenome(s) do(s) autor(es) com a
indicação do número. Neste caso, a
citação será pelo sobrenome de cada
autor ou pelo nome da entidade
responsável que aparece na respectiva
referência. Quando se tratar de três
autores, todos devem ser citados. No caso
de mais de três autores, a citação deve
ser acompanhada pelo sobrenome do
primeiro autor seguido da expressão et
al. (sem itálico). Se a citação estiver
inserida no texto utilizar letras maiúsculas
e minúsculas; se estiver entre parênteses






Soares e Alves13 ou (SOARES; ALVES13)
Três autores
Bennett, Abee e Henrickson12 ou
(BENNETT; ABEE; HENRICKSON12)
Quatro ou mais autores
Vilela, Martins, Bressan e Carvalho26 ou
Vilela et al.26
(VILELA; MARTINS; BRESSAN;
CARVALHO26 ) OU (VILELA et al. 26)
Tarifa de publicação: A tarifa de
publicação de R$ 40,00, por página
impressa, será cobrada do autor indicado
para correspondência, por ocasião da
prova final do artigo. Se houver
necessidade de impressão em cores, as
despesas correrão por conta dos autores.
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INSTRUCTIONS TO AUTHORS
Mission and Editorial policy
The Brazilian Journal of Veterinary Research and
Animal Science publishes scientific complete articles
and high quality previous notes relative to the field
of veterinary medicine as well as to veterinarians.
Studies of the basic and applied sciences relative to
veterinary medicine are welcome. Only previous
notes that address matters of veterinary science and
provide supporting scientific evidences will be
published. The manuscripts will be analyzed by the
Editorial Board, provided they adhere to the
manuscript guidelines.
It is the official publication of Fundação Medicina
Veterinária – FUMVET. The journal follows the
guidelines established by the Editorial Board
designated by the Faculdade de Medicina
Veterinária e Zootecnia da Universidade de São
Paulo. Articles and their concepts are sole
responsibility of author (s).
Articles will be accepted for publication provided
they adhere to the Author’s guidelines and receive
approval from the Scientific Committee and the
Editorial Board, after hearing the reviewers.
Reviewers maintain confidentiality of the
information presented in the manuscript. Reviewers
should render their opinions in an unbiased and
ethical manner. Identity of reviewers is kept secret.
Once an article is approved for publication by the
Scientific Committee, a fee (R$) will be charged
which will be calculated on the basis of number of
pages. All authors should sign a form declaring they
are aware and obliged to this payment when
submitting a manuscript. After approval for
publication, provided no payment was made,
manuscript course of action will stop and
manuscript returned to the authors.
Historical background
This periodical was founded in 1938 by the
Faculdade de Medicina Veterinária which was part
of Universidade de São Paulo. The periodical’s
former name was Revista da Faculdade de Medicina
Veterinária da Universidade de São Paulo. In 1974,
its name was changed to Revista da Faculdade de
Medicina Veterinária e Zootecnia da Universidade
de São Paulo, following the name change of the
school. In 1990, its name was again changed,
bearing the present denomination of Brazilian
Journal of Veterinary Research and Animal Science.
In 2000, the journal became the official publication
of the Fundação Medicina Veterinária – FUMVET,
setting away the institutional link with the Faculdade
de Medicina Veterinária e Zootecnia da USP.
Correspondence address
Manuscripts and all letters should be sent to the
following address:
Brazilian Journal of Veterinary Research and
Animal Science
Universidade de São Paulo
Faculdade de Medicina Veterinária e Zootecnia
Seção de Publicação
Av. Prof. Dr. Orlando Marques de Paiva, 87 -
Cidade Universitária Armando de Salles Oliveira
05508-270 - São Paulo - SP - Brasil
Telefone: (0XX11) 3091-7636
Fax: (0XX11) 3032-2224; 3031-3074; 3091-
7672/7678
e-mail: brazvet@edu.usp.br
versão on line: http://www.scielo.br/bjvras
AUTHOR’S GUIDELINES
Complete article
1 – Articles must describe original research and
should be submitted only to Brazilian Journal of
Veterinary Research and Animal Science. It is
necessary to include a form, signed by all authors,
in which authors agree to the payment of
publication fees.
2 – Manuscripts should be limited to ten written
pages following the structure depicted in the item
#5. Page tables and figures are not counted.
3 – Articles must be written in Portuguese or in
English.
4- Use only official nomenclature. The use of
author-defined abbreviations and acronyms is
discouraged. Abbreviations in the titles should be
avoided.
5 – Articles must be structured within the
following sections:
a) Introduction






The items Results, Discussion and Conclusions
may be included in a single section, except
otherwise indicated by the Editorial Board.
6 – Authors must submit two abstracts, one in
Portuguese and another in English, which should
consist of no more than 250 words. The Abstract
is followed by up to five key-words which should
correspond to words or expressions that identify
the contents of the article.
Previous note
1 - All Previous Notes must describe original
research and should be submitted only to
Brazilian Journal of Veterinary Research and
Animal Science. It is necessary to include a form,
signed by all authors, in which authors agree to
the payment of publication fees.
2 – Should be up to three typed pages.
3 – Articles must be written in Portuguese or in
English.
4- Use only official nomenclature. The use of
author-defined abbreviations and acronyms is
discouraged.
5 – Previous Notes must not be divided into
major headings (Introduction, Materials and
Methods, etc.), but should present two abstracts
followed by key-words as it was described for
complete manuscript submission, including a list
of References.
Review articles
Unsolicited review manuscripts will not be
accepted; however, a draft may be submitted to
the Editorial Board, without previous consent,
aiming at appropriateness for publication. The
Editorial Board may invite renowned specialists to
submit review manuscripts.
These reviews must adhere to the guidelines of a
complete article, though without division into
major headings (Introduction, Materials and
Methods, etc.). They should present two abstracts
followed by key-words as it was described for
complete article submission, including a list of
References.
Manuscript submission
1 – Typesetting: manuscripts should be
submitted in CD-ROM or 3½” high density
diskette. They have to bear manuscript’s title and
author’s name (s). Authors must submit three
copies of the manuscript, including tables and
references, double-space typed and pages
numbered consecutively. Page size is A4 (21.0 ´
29.7 cm) and 2.5 cm for all margins. Use only
front page and fixed character width (Times New
Roman 10 cpi). Illustrations and legends must
come on separate sheets. Authors must choose
Microsoft Word as text editor.
2 – Cover page: all manuscripts must include a
cover page containing the manuscript’s title,
author’s name (s) and institution. In the footnote
should be given the complete address (including
e-mail) of the corresponding author. Care should
be observed that author’s identification is
supposed to appear only in the cover page to
assure unbiased and ethical reviews. If the work
received financial assistance from the industry,
mention to it as well as acknowledgment should
be provided.
3 – Tables: tables are numbered consecutively in
Arabic numbers. For table construction follow:
IBGE. Normas de apresentação tabular. 3. ed. Rio
de Janeiro: IBGE, 1993. 61p. Upper limit of
tables per work is five. Exceptionally, after hearing
the Editorial Board, this number might be
increased. In the text, reference to the table
content is indicated by the word Table.
4 – Illustrations (photographs, graphics,
drawings or artwork): illustrations must be
numbered consecutively in Arabic numbers and
be cited in the text as Figures. The photographs
shall be identified only by the manuscript’s title
and on the back contain description of correct
positioning in the text. Graphics, drawings or
artwork should be provided in separate sheets,
identified by the manuscript’s title and respective
legends. All illustrations must be provided in
three copies. Be sure that each mean and some
index of variation is presented in the figures, the
figure legend, or the text. Drawings and other
artworks must have good technical quality and
artistically accepted (in the case they are computer
generated, printed originals must be included).
Upper limit of figures per work is nine and it is
suggested the following distribution: three
photographs, three graphics and three drawings
or artworks. Beyond this limit expenses with
reproduction shall be the author’s responsibility.
Color photographs, independently of number,
will be charged.
5- References: they must appear in the order they
were cited in the text. Periodical or journal names
must be uniform, preferentially not abbreviated. In
the case, periodical or journal names are
abbreviated, follow the NBR 6032. For references
that are not illustrated in this Instructions to Authors
follow instructions contained in the NBR 6023/
2002. Indicate authors by last name, in capital letters,
followed by initials of first and middle names.
Authors are separated by semicolon and space.
Examples: BONAGURA, J. D. [...] (1 author)
SANTOS, J. A.; MELLO, M. R. [...] (2 authors)
BENNETT, B. T.; ABEE, C. R.; HENRICKSON, R. [...]
(3 authors)
VILELA, D.; MARTINS, C. E.; BRESSAN, M.;
CARVALHO, L. A. [...] (4 authors or more) or VILELA,
D. et al. [...].
Example of periodical or journal
KOTZEKIDOV, P.; BLOUKAS, J. G. Effect of
protective cultures and packaging film
permeatibility on shelf-life of sliced vacuum-
pocked cooked ham. Meat Science, v.42, n.3, p.
333-45, 1996.
Example of book
HALLIWELL, R. E. W.; GORMAN, N. T.
Veterinary clinical immunology. London: W. B.
Saunders, 1989. 548 p.
Example of chapter and book with different
authors
FENNER, W. R. Avaliação neurológica dos
pacientes. In: ETTINGER, S.J. Tratado de
medicina interna veterinária. 3. ed. São Paulo:
Manole, 1992.   p. 577-606.
Example of same authorship for chapter and book
THORTON, H. Deleterius changes in meat. In:
THORTON, H. Aspects of meat inspection.
London: Thindall & Cassel, 1973. p. 63-72.
Example of thesis
BIRGEL, E. H. Estudo do quadro eritrocitário de
caprinos (Capra hircus, L.) normais criados no
Estado de São Paulo: influências de fatores
raciais, sexuais, etários e alimentares, 1973. 92 f.
Tese (Livre Docência) - Faculdade de Medicina
Veterinária e Zootecnia, Universidade de São
Paulo, São Paulo.
Example of meeting
OLIVEIRA, C. A. Hormonoterapia em cadelas e
gatas. In: CONGRESSO BRASILEIRO DE
REPRODUÇÃO ANIMAL, 9., 1991, Belo
Horizonte. Anais... Belo Horizonte: Colégio
Brasileiro de Reprodução Animal, 1991. p. 100-
111.
Example of electronic publication
AUTHOR. Title. Edition. Local of publication:
Publisher, year of publication. (Type and
characteristics of midia support, producer,
citation date, availability and access).
ONLINE
POORE, M. H. Alternative feeds for beef cattle.
North Carolina: North Carolina Corporative
Extension Service, 1994. Disponível em: <http://
www.ces.ncsu.edu/drought/dro-28.html>.
Acesso em: 23 abr. 1997.
Online – must cite web page address and date it
that was accessed.
Example of articles from electronic journals
AUTHOR. TITLE OF ARTICLE. Title of
periodical, volume, issue (number), pages, year of
publication. (Type and characteristics of midia
support, producer, citation date, availability and
access).
ONLINE
MENDONÇA JR., C.X.; MARTINS, A.P.; MORI,
A.V.; SILVA, A.B.; MORI, C.S. Efeito da adição de
óleo de peixe à dieta sobre o desempenho e
níveis de lípides plasmáticos e de colesterol no
ovo de galinhas poedeiras. Brazilian Journal of
Veterinary Research and Animal Science, v.37,
n.1, 2000. Disponível em: <http://
www.scielo.br/cgi_bin/wxis.exe/iach/scielo>.
Acesso em: 31 jan. 2001
Online – must cite web page address and date it
that was accessed.
6 - Citations in the text: must be consecutively
numbered with Arabic numerals as superscripts
in the order they first appear in the text. When
absolutely necessary to use author’s name,
combine author’s last name with its
corresponding numeral as superscript.
References containing up to three authors must
cite all of them. References with more than three
authors must cite the first one’s last name
followed by the expression et al. (not italic). Only
the first letter of name is capitalized; however, if
author’s last name is inserted between
parenthesis, all letters must be capitalized.
Examples: According to Yanaguita9 [...]
[...] (YANAGUITA9) [...]
Bennett, Abee and Henrickson12 [...]
Vilela, Martins, Bressan and Carvalho26 [...]
(4 authors or more) or (VILELA et al.26) [...]
